Premalignant Lesions of the Anal Canal and Squamous Cell Carcinoma of the Anal Canal

ABSTRACT

Squamous cell carcinoma of the anus (SCCA) is a rare tumor. However, its incidence has been increasing in men and women over the past 25 years worldwide. Risk factors associated with this cancer are those behaviors that predispose individuals to human papillomavirus (HPV) infection and immunosuppression. Anal cancer is generally preceded by high-grade anal intraepithelial neoplasia (HGAIN), which is most prevalent in human immunodeficiency virus-positive men who have sex with men. High-risk patients may benefit from screening. The most common presentation is rectal bleeding, which is present in nearly 50% of patients. Twenty percent of patients have no symptoms at the time of presentation. Clinical staging of anal cancer requires a digital rectal exam and a positron emission tomography/computed tomography scan of the chest, abdomen, and pelvis. Endorectal/endoanal ultrasound appears to add more-specific staging information when compared with digital rectal examination alone. Treatment of anal cancer prior to the 1970s involved an abdominoperineal resection. However, the current standard of care for localized anal cancer is concurrent chemoradiation therapy, primarily because of its sphincter-saving and colostomy-sparing potential. Studies have addressed alternative chemoradiation regimens to improve the standard protocol of fluorouracil, misogynic, and radiation, but no alternative regimen has proven superior. Surgery is reserved for those patients with residual disease or recurrence.

KEYWORDS

Squamous cell carcinoma - anal margin - neoplasms

REFERENCES

• 1 Welton M L, Varma M G. Anal cancer. In: Wolff B G, Fleshman J W, Beck D E, et al. The ASCRS Textbook of Colon and Rectal Surgery. New York: Springer; 2007: 482-500
• 2 Bullard D K, Rothenberger D. Colon, rectum and anus. In: Brunicardi C, ed. Schwartz's Principles of Surgery. New York: McGraw Hill; 2008
• 3 Friedman H B, Saah A J, Sherman M E et al.. Human papillomavirus, anal squamous intraepithelial lesions, and human immunodeficiency virus in a cohort of gay men.  J Infect Dis. 1998;  178 (1) 45-52
• 4 Ogunbiyi O A, Scholefield J H, Raftery A T et al.. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients.  Br J Surg. 1994;  81 (3) 365-367
• 5 Martin F, Bower M. Anal intraepithelial neoplasia in HIV positive people.  Sex Transm Infect. 2001;  77 (5) 327-331
• 6 Critchlow C W, Surawicz C M, Holmes K K et al.. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection.  AIDS. 1995;  9 (11) 1255-1262
• 7 Palefsky J M, Holly E A, Ralston M L et al.. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors.  J Acquir Immune Defic Syndr Hum Retrovirol. 1998;  17 (4) 320-326
• 8 Palefsky J M, Holly E A, Ralston M L, Jay N, Berry J M, Darragh T M. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men.  AIDS. 1998;  12 (5) 495-503
• 9 Palefsky J M, Shiboski S, Moss A. Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men.  J Acquir Immune Defic Syndr. 1994;  7 (6) 599-606
• 10 Caussy D, Goedert J J, Palefsky J et al.. Interaction of human immunodeficiency and papilloma viruses: association with anal epithelial abnormality in homosexual men.  Int J Cancer. 1990;  46 (2) 214-219
• 11 Schiffman M H. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia.  J Natl Cancer Inst. 1992;  84 (6) 394-398
• 12 Chin-Hong P V, Vittinghoff E, Cranston R D et al.. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.  J Natl Cancer Inst. 2005;  97 (12) 896-905
• 13 Palefsky J M, Holly E A, Ralston M L, Greenblatt R M. Da Costa M . Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.  J Infect Dis. 2001;  183 (3) 383-391
• 14 Melbye M, Smith E, Wohlfahrt J et al.. Anal and cervical abnormality in women—prediction by human papillomavirus tests.  Int J Cancer. 1996;  68 (5) 559-564
• 15 Williams A B, Darragh T M, Vranizan K, Ochia C, Moss A R, Palefsky J M. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women.  Obstet Gynecol. 1994;  83 (2) 205-211
• 16 Nielson C M, Harris R B, Dunne E F et al.. Risk factors for anogenital human papillomavirus infection in men.  J Infect Dis. 2007;  196 (8) 1137-1145
• 17 Nyitray A, Nielson C M, Harris R B et al.. Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men.  J Infect Dis. 2008;  197 (12) 1676-1684
• 18 Frisch M. On the etiology of anal squamous carcinoma.  Dan Med Bull. 2002;  49 (3) 194-209
• 19 Zbar A P, Fenger C, Efron J, Beer-Gabel M, Wexner S D. The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulvar intraepithelial carcinoma.  Int J Colorectal Dis. 2002;  17 (4) 203-215
• 20 Frisch M, Fenger C, van den Brule A J et al.. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses.  Cancer Res. 1999;  59 (3) 753-757
• 21 Bjørge T, Engeland A, Luostarinen T et al.. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study.  Br J Cancer. 2002;  87 (1) 61-64
• 22 Kreuter A, Brockmeyer N H, Hochdorfer B et al.. Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection.  J Am Acad Dermatol. 2005;  52 (4) 603-608
• 23 Palefsky J M, Gonzales J, Greenblatt R M, Ahn D K, Hollander H. Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV HIV disease.  JAMA. 1990;  263 (21) 2911-2916
• 24 Palefsky J M, Holly E A, Hogeboom C J et al.. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men.  J Acquir Immune Defic Syndr Hum Retrovirol. 1998;  17 (4) 314-319
• 25 Hessol N A, Pipkin S, Schwarcz S, Cress R D, Bacchetti P, Scheer S. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.  Am J Epidemiol. 2007;  165 (10) 1143-1153
• 26 Palefsky J M, Holly E A, Efirdc J T et al.. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men.  AIDS. 2005;  19 (13) 1407-1414
• 27 Holly E A, Ralston M L, Darragh T M, Greenblatt R M, Jay N, Palefsky J M. Prevalence and risk factors for anal squamous intraepithelial lesions in women.  J Natl Cancer Inst. 2001;  93 (11) 843-849
• 28 Scholefield J H, Sonnex C, Talbot I C et al.. Anal and cervical intraepithelial neoplasia: possible parallel.  Lancet. 1989;  2 (8666) 765-769
• 29 Palefsky J M. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem.  AIDS. 1994;  8 (3) 283-295
• 30 Schneider T C, Schulte W J. Management of carcinoma of anal canal.  Surgery. 1981;  90 (4) 729-734
• 31 Schraut W H, Wang C H, Dawson P J, Block G E. Depth of invasion, location, and size of cancer of the anus dictate operative treatment.  Cancer. 1983;  51 (7) 1291-1296
• 32 DeVita V TL, Theodore S, Rosenberg S A. Devita, Hellman and Rosenberg's Cancer: Principles & Practice of Oncology. Vol 1. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2008
• 33 Palefsky J M, Rubin M. The epidemiology of anal human papillomavirus and related neoplasia.  Obstet Gynecol Clin North Am. 2009;  36 (1) 187-200
• 34 Chang G J, Berry J M, Jay N, Palefsky J M, Welton M L. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study.  Dis Colon Rectum. 2002;  45 (4) 453-458
• 35 Benson C A, Kaplan J E, Masur H, Pau A, Holmes K K. CDC;National Institutes of Health Infectious Diseases Society of America . Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.  MMWR Recomm Rep. 2004;  53 (RR-15) 1-112
• 36 Chin-Hong P V, Berry J M, Cheng S C et al.. Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men.  Ann Intern Med. 2008;  149 (5) 300-306
• 37 Panther L A, Wagner K, Proper J et al.. High resolution anoscopy findings for men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus.  Clin Infect Dis. 2004;  38 (10) 1490-1492
• 38 Palefsky J M, Holly E A, Hogeboom C J, Berry J M, Jay N, Darragh T M. Anal cytology as a screening tool for anal squamous intraepithelial lesions.  J Acquir Immune Defic Syndr Hum Retrovirol. 1997;  14 (5) 415-422
• 39 Devaraj B, Cosman B C. Expectant management of anal squamous dysplasia in patients with HIV.  Dis Colon Rectum. 2006;  49 (1) 36-40
• 40 Watson A J, Smith B B, Whitehead M R, Sykes P H, Frizelle F A. Malignant progression of anal intra-epithelial neoplasia.  ANZ J Surg. 2006;  76 (8) 715-717
• 41 Scholefield J H, Castle M T, Watson N F. Malignant transformation of high-grade anal intraepithelial neoplasia.  Br J Surg. 2005;  92 (9) 1133-1136
• 42 Berry J M, Palefsky J M, Jay N, Cheng S C, Darragh T M, Chin-Hong P V. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia.  Dis Colon Rectum. 2009;  52 (2) 239-247
• 43 Goldie S J, Kuntz K M, Weinstein M C, Freedberg K A, Welton M L, Palefsky J M. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.  JAMA. 1999;  281 (19) 1822-1829
• 44 Graham B D, Jetmore A B, Foote J E, Arnold L K. Topical 5-fluorouracil in the management of extensive anal Bowen's disease: a preferred approach.  Dis Colon Rectum. 2005;  48 (3) 444-450
• 45 Rosen T, Harting M, Gibson M. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study.  Dermatol Surg. 2007;  33 (4) 427-431, discussion 431–432
• 46 Kreuter A, Potthoff A, Brockmeyer N H German Competence Network HIV/AIDS et al. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men.  J Invest Dermatol. 2008;  128 (8) 2078-2083
• 47 Holt P J. Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery.  Br J Dermatol. 1988;  119 (2) 231-240
• 48 Runfola M A, Weber T K, Rodriguez-Bigas M A, Dougherty T J, Petrelli N J. Photodynamic therapy for residual neoplasms of the perianal skin.  Dis Colon Rectum. 2000;  43 (4) 499-502
• 49 Stier E A, Goldstone S E, Berry J M et al.. Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: an AIDS malignancy consortium pilot study.  J Acquir Immune Defic Syndr. 2008;  47 (1) 56-61
• 50 Strauss R J, Fazio V W. Bowen's disease of the anal and perianal area. A report and analysis of twelve cases.  Am J Surg. 1979;  137 (2) 231-234
• 51 Margenthaler J A, Dietz D W, Mutch M G, Birnbaum E H, Kodner I J, Fleshman J W. Outcomes, risk of other malignancies, and need for formal mapping procedures in patients with perianal Bowen's disease.  Dis Colon Rectum. 2004;  47 (10) 1655-1660, discussion 1660–1661
• 52 Pineda C E, Berry J M, Jay N, Palefsky J M, Welton M L. High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience.  Dis Colon Rectum. 2008;  51 (6) 829-835, discussion 835–837
• 53 Fleshner P R, Chalasani S, Chang G J, Levien D H, Hyman N H, Buie W D. Standards Practice Task Force, American Society of Colon and Rectal Surgeons . Practice parameters for anal squamous neoplasms.  Dis Colon Rectum. 2008;  51 (1) 2-9
• 54 De Vuyst H, Clifford G M, Nascimento M C, Madeleine M M, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis.  Int J Cancer. 2009;  124 (7) 1626-1636
• 55 Gillison M L, Chaturvedi A K, Lowy D R. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.  Cancer. 2008;  113 (10 Suppl) 3036-3046
• 56 Berry J M, Palefsky J M. A review of human papillomavirus vaccines: from basic science to clinical trials.  Front Biosci. 2003;  8 s333-s345
• 57 Ryan D P, Compton C C, Mayer R J. Carcinoma of the anal canal.  N Engl J Med. 2000;  342 (11) 792-800
• 58 Ries L AG, Harkins D, Krapcho M et al, Eds.. SEER Cancer Statistics Review, 1975–2003. Baltimore, MD: National Cancer Institute; 2005: 1-103
• 59 Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M J. Cancer statistics, 2009.  CA Cancer J Clin. 2009;  59 (4) 225-249
• 60 Johnson L G, Madeleine M M, Newcomer L M, Schwartz S M, Daling J R. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000.  Cancer. 2004;  101 (2) 281-288
• 61 Daling J R, Weiss N S, Klopfenstein L L, Cochran L E, Chow W H, Daifuku R. Correlates of homosexual behavior and the incidence of anal cancer.  JAMA. 1982;  247 (14) 1988-1990
• 62 Edge S B, Byrd D R, Compton C C et al.. AJCC (American Joint Committee on Cancer) Cancer Staging Manual. 7th ed. New York: Springer; 2010: 165-176
• 63 Myerson R J, Karnell L H, Menck H R. The National Cancer Data Base report on carcinoma of the anus.  Cancer. 1997;  80 (4) 805-815
• 64 Buckwalter J A, Jurayj M N. Relationship of chronic anorectal disease to carcinoma.  AMA Arch Surg. 1957;  75 (3) 352-360, discussion 360–361
• 65 Frisch M, Olsen J H, Bautz A, Melbye M. Benign anal lesions and the risk of anal cancer.  N Engl J Med. 1994;  331 (5) 300-302
• 66 Holly E A, Whittemore A S, Aston D A, Ahn D K, Nickoloff B J, Kristiansen J J. Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking.  J Natl Cancer Inst. 1989;  81 (22) 1726-1731
• 67 Slater G, Greenstein A, Aufses Jr A H. Anal carcinoma in patients with Crohn's disease.  Ann Surg. 1984;  199 (3) 348-350
• 68 Frisch M, Johansen C. Anal carcinoma in inflammatory bowel disease.  Br J Cancer. 2000;  83 (1) 89-90
• 69 Welton M L, Sharkey F E, Kahlenberg M S. The etiology and epidemiology of anal cancer.  Surg Oncol Clin N Am. 2004;  13 (2) 263-275
• 70 Daling J R, Weiss N S, Hislop T G et al.. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer.  N Engl J Med. 1987;  317 (16) 973-977
• 71 Daling J R, Sherman K J, Hislop T G et al.. Cigarette smoking and the risk of anogenital cancer.  Am J Epidemiol. 1992;  135 (2) 180-189
• 72 Daling J R, Madeleine M M, Johnson L G et al.. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer.  Cancer. 2004;  101 (2) 270-280
• 73 Frisch M, Glimelius B, van den Brule A J et al.. Sexually transmitted infection as a cause of anal cancer.  N Engl J Med. 1997;  337 (19) 1350-1358
• 74 Frisch M, Olsen J H, Melbye M. Malignancies that occur before and after anal cancer: clues to their etiology.  Am J Epidemiol. 1994;  140 (1) 12-19
• 75 Melbye M, Sprøgel P. Aetiological parallel between anal cancer and cervical cancer.  Lancet. 1991;  338 (8768) 657-659
• 76 Rabkin C S, Biggar R J, Melbye M, Curtis R E. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors.  Am J Epidemiol. 1992;  136 (1) 54-58
• 77 Bjørge T, Engeland A, Luostarinen T et al.. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study.  Br J Cancer. 2002;  87 (1) 61-64
• 78 Scholefield J H, Kerr I B, Shepherd N A, Miller K J, Bloomfield R, Northover J M. Human papillomavirus type 16 DNA in anal cancers from six different countries.  Gut. 1991;  32 (6) 674-676
• 79 Williams G R, Lu Q L, Love S B, Talbot I C, Northover J M. Properties of HPV-positive and HPV-negative anal carcinomas.  J Pathol. 1996;  180 (4) 378-382
• 80 Hernandez B Y, McDuffie K, Zhu X et al.. Anal human papillomavirus infection in women and its relationship with cervical infection.  Cancer Epidemiol Biomarkers Prev. 2005;  14 (11 Pt 1) 2550-2556
• 81 Sillman F H, Sentovich S, Shaffer D. Ano-genital neoplasia in renal transplant patients.  Ann Transplant. 1997;  2 (4) 59-66
• 82 Adami J, Gäbel H, Lindelöf B et al.. Cancer risk following organ transplantation: a nationwide cohort study in Sweden.  Br J Cancer. 2003;  89 (7) 1221-1227
• 83 Patel H S, Silver A R, Northover J M. Anal cancer in renal transplant patients.  Int J Colorectal Dis. 2007;  22 (1) 1-5
• 84 Penn I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases.  Cancer. 1986;  58 (3) 611-616
• 85 Patel P, Hanson D L, Sullivan P S Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003.  Ann Intern Med. 2008;  148 (10) 728-736
• 86 Tanum G, Tveit K, Karlsen K O. Diagnosis of anal carcinoma—doctor's finger still the best?.  Oncology. 1991;  48 (5) 383-386
• 87 Ryan D P, Compton C C, Mayer R J. Carcinoma of the anal canal.  N Engl J Med. 2000;  342 (11) 792-800
• 88 Flam M, John M, Pajak T F et al.. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.  J Clin Oncol. 1996;  14 (9) 2527-2539
• 89 Gordon P H. Current status—perianal and anal canal neoplasms.  Dis Colon Rectum. 1990;  33 (9) 799-808
• 90 Wade D S, Herrera L, Castillo N B, Petrelli N J. Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique.  Surg Gynecol Obstet. 1989;  169 (3) 238-242
• 91 Trautmann T G, Zuger J H. Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal.  Mol Imaging Biol. 2005;  7 (4) 309-313
• 92 Cotter S E, Grigsby P W, Siegel B A et al.. FDG-PET/CT in the evaluation of anal carcinoma.  Int J Radiat Oncol Biol Phys. 2006;  65 (3) 720-725
• 93 Winton E, Heriot A G, Ng M et al.. The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer.  Br J Cancer. 2009;  100 (5) 693-700
• 94 Giovannini M, Bardou V J, Barclay R et al.. Anal carcinoma: prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study.  Endoscopy. 2001;  33 (3) 231-236
• 95 Roseau G, Palazzo L, Colardelle P, Chaussade S, Couturier D, Paolaggi J A. Endoscopic ultrasonography in the staging and follow-up of epidermoid carcinoma of the anal canal.  Gastrointest Endosc. 1994;  40 (4) 447-450
• 96 Giovannini M, Bardou V J, Barclay R et al.. Anal carcinoma: prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study.  Endoscopy. 2001;  33 (3) 231-236
• 97 Christensen A F, Nielsen M B, Engelholm S A, Roed H, Svendsen L B, Christensen H. Three-dimensional anal endosonography may improve staging of anal cancer compared with two-dimensional endosonography.  Dis Colon Rectum. 2004;  47 (3) 341-345
• 98 Salmon R J, Zafrani B, Labib A, Asselain B, Girodet J. Prognosis of cloacogenic and squamous cancers of the anal canal.  Dis Colon Rectum. 1986;  29 (5) 336-340
• 99 Cummings B J. Treatment of primary epidermoid carcinoma of the anal canal.  Int J Colorectal Dis. 1987;  2 (2) 107-112
• 100 UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research . Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin.  Lancet. 1996;  348 (9034) 1049-1054
• 101 Bilimoria K Y, Bentrem D J, Rock C E, Stewart A K, Ko C Y, Halverson A. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.  Dis Colon Rectum. 2009;  52 (4) 624-631
• 102 Boman B M, Moertel C G, O'Connell M J et al.. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases.  Cancer. 1984;  54 (1) 114-125
• 103 Pintor M P, Northover J M, Nicholls R J. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984.  Br J Surg. 1989;  76 (8) 806-810
• 104 Greenall M J, Quan S H, Urmacher C, DeCosse J J. Treatment of epidermoid carcinoma of the anal canal.  Surg Gynecol Obstet. 1985;  161 (6) 509-517
• 105 Dougherty B G, Evans H L. Carcinoma of the anal canal: a study of 79 cases.  Am J Clin Pathol. 1985;  83 (2) 159-164
• 106 Nigro N D, Vaitkevicius V K, Considine Jr B. Combined therapy for cancer of the anal canal: a preliminary report.  Dis Colon Rectum. 1974;  17 (3) 354-356
• 107 Nigro N D, Seydel H G, Considine B, Vaitkevicius V K, Leichman L, Kinzie J J. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal.  Cancer. 1983;  51 (10) 1826-1829
• 108 Leichman L, Nigro N, Vaitkevicius V K et al.. Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy.  Am J Med. 1985;  78 (2) 211-215
• 109 Flam M S, John M J, Mowry P A, Lovalvo L J, Ramalho L D, Wade J. Definitive combined modality therapy of carcinoma of the anus. A report of 30 cases including results of salvage therapy in patients with residual disease.  Dis Colon Rectum. 1987;  30 (7) 495-502
• 110 John M J, Flam M, Lovalvo L, Mowry P A. Feasibility of non-surgical definitive management of anal canal carcinoma.  Int J Radiat Oncol Biol Phys. 1987;  13 (3) 299-303
• 111 Flam M, John M, Pajak T F et al.. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.  J Clin Oncol. 1996;  14 (9) 2527-2539
• 112 Bartelink H, Roelofsen F, Eschwege F et al.. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.  J Clin Oncol. 1997;  15 (5) 2040-2049
• 113 Cummings B J, Keane T J, O'Sullivan B, Wong C S, Catton C N. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.  Int J Radiat Oncol Biol Phys. 1991;  21 (5) 1115-1125
• 114 Peiffert D, Seitz J F, Rougier P et al.. Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study.  Ann Oncol. 1997;  8 (6) 575-581
• 115 Martenson J A, Lipsitz S R, Wagner Jr H et al.. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study.  Int J Radiat Oncol Biol Phys. 1996;  35 (4) 745-749
• 116 Ajani J A, Winter K A, Gunderson L L et al.. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.  JAMA. 2008;  299 (16) 1914-1921
• 117 James R, Wan S, Glynne-Jones R et al.. A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II).  J Clin Oncol. 2009;  27 (18S) LBA4009
• 118 Deniaud-Alexandre E, Touboul E, Tiret E et al.. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal.  Int J Radiat Oncol Biol Phys. 2003;  56 (5) 1259-1273
• 119 Newman G, Calverley D C, Acker B D, Manji M, Hay J, Flores A D. The management of carcinoma of the anal canal by external beam radiotherapy, experience in Vancouver 1971–1988.  Radiother Oncol. 1992;  25 (3) 196-202
• 120 Martenson Jr J A, Gunderson L L. External radiation therapy without chemotherapy in the management of anal cancer.  Cancer. 1993;  71 (5) 1736-1740
• 121 Otim-Oyet D, Ford H T, Fisher C, Crow J, Horwich A. Radical radiotherapy for carcinoma of the anal canal.  Clin Oncol (R Coll Radiol). 1990;  2 (2) 84-89
• 122 Zilli T, Schick U, Ozsahin M et al.. 6628 Node negative T1–2 anal cancer: radiotherapy alone or concomitant radio-chemotherapy?.  Eur J Cancer Suppl. 2009;  7 (2) 398-402
• 123 National Comprehensive Cancer Network. NCCN guidelines. Available at: http://www.nccn.org Accessed February 1, 2011
• 124 Cleator S, Fife K, Nelson M, Gazzard B, Phillips R, Bower M. Treatment of HIV-associated invasive anal cancer with combined chemoradiation.  Eur J Cancer. 2000;  36 (6) 754-758
• 125 Stadler R F, Gregorcyk S G, Euhus D M, Place R J, Huber P J, Simmang C L. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.  Dis Colon Rectum. 2004;  47 (8) 1305-1309
• 126 Kim J H, Sarani B, Orkin B A et al.. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients.  Dis Colon Rectum. 2001;  44 (10) 1496-1502
• 127 Place R J, Gregorcyk S G, Huber P J, Simmang C L. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma.  Dis Colon Rectum. 2001;  44 (4) 506-512
• 128 Blazy A, Hennequin C, Gornet J M et al.. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy.  Dis Colon Rectum. 2005;  48 (6) 1176-1181
• 129 Fraunholz I, Weiss C, Eberlein K, Haberl A, Rödel C. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.  Int J Radiat Oncol Biol Phys. 2010;  76 (5) 1425-1432
• 130 Stadler R F, Gregorcyk S G, Euhus D M et al.. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.  Dis Colon Rectum. 2009;  47 (8) 1305-1309
• 131 Hogg M E, Popowich D A, Wang E C, Kiel K D, Stryker S J, Halverson A L. HIV and anal cancer outcomes: a single institution's experience.  Dis Colon Rectum. 2009;  52 (5) 891-897
• 132 Oehler-Jänne C, Huguet F, Provencher S et al.. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.  J Clin Oncol. 2008;  26 (15) 2550-2557
• 133 Clark M A, Hartley A, Geh J I. Cancer of the anal canal.  Lancet Oncol. 2004;  5 (3) 149-157
• 134 Nilsson P J, Svensson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer.  Br J Surg. 2002;  89 (11) 1425-1429
• 135 Faynsod M, Vargas H I, Tolmos J et al.. Patterns of recurrence in anal canal carcinoma.  Arch Surg. 2000;  135 (9) 1090-1093, discussion 1094–1095
• 136 Khater R, Frenay M, Bourry J, Milano G, Namer M. Cisplatin plus 5-fluorouracil in the treatment of metastatic anal squamous cell carcinoma: a report of two cases.  Cancer Treat Rep. 1986;  70 (11) 1345-1346
• 137 Jaiyesimi I A, Pazdur R. Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal.  Am J Clin Oncol. 1993;  16 (6) 536-540
• 138 Fisher W B, Herbst K D, Sims J E, Critchfield C F. Metastatic cloacogenic carcinoma of the anus: sequential responses to adriamycin and cis-dichlorodiammineplatinum(II).  Cancer Treat Rep. 1978;  62 (1) 91-97
• 139 Zimm S, Wampler G L. Response of metastatic cloacogenic carcinoma to treatment with semustine.  Cancer. 1981;  48 (12) 2575-2576
• 140 Kounalakis N, Artinyan A, Smith D, Mojica-Manoso P, Paz B, Lai L L. Abdominal perineal resection improves survival for nonmetastatic adenocarcinoma of the anal canal.  Ann Surg Oncol. 2009;  16 (5) 1310-1315
• 141 Beal K P, Wong D, Guillem J G et al.. Primary adenocarcinoma of the anus treated with combined modality therapy.  Dis Colon Rectum. 2003;  46 (10) 1320-1324